MultiCell Technologies, Inc. (MCET)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2014 | -722.81 USD | 47.16% |
| 2013 | -1368.03 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2015 Q3 | -176.95 USD | -177.61% |
| 2015 Q1 | -288.88 USD | -19.31% |
| 2015 Q2 | 228.01 USD | 178.93% |
| 2014 Q3 | 198.69 USD | 153.72% |
| 2014 Q2 | -369.89 USD | -19.51% |
| 2014 Q4 | -242.12 USD | -221.86% |
| 2014 FY | -722.81 USD | 47.16% |
| 2014 Q1 | -309.49 USD | 19.92% |
| 2013 FY | -1368.03 USD | 0.0% |
| 2013 Q3 | -343.79 USD | 0.0% |
| 2013 Q4 | -386.47 USD | -12.41% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 99.946% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 99.986% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 99.996% |
| Nascent Biotech, Inc. | -2.22 Million USD | 99.968% |
| Rebus Holdings, Inc. | -664 Thousand USD | 99.891% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 100.001% |
| Qrons Inc. | -643.67 Thousand USD | 99.888% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 99.814% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 99.999% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 99.826% |
| Skye Bioscience, Inc. | -13.67 Million USD | 99.995% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 99.999% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 100.015% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 99.724% |
| SQZ Biotechnologies Company | -75.82 Million USD | 99.999% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 99.975% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 99.953% |
| Mesoblast Limited | -84.14 Million USD | 99.999% |
| Marizyme, Inc. | -34.08 Million USD | 99.998% |
| Genus plc | 6.4 Million USD | 100.011% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 100.007% |
| Pharming Group N.V. | -4.87 Million USD | 99.985% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 99.964% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 99.922% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 99.991% |
| ContraFect Corporation | -56.88 Million USD | 99.999% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 99.984% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 99.948% |
| IMV Inc. | -38.67 Million USD | 99.998% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 99.974% |
| ONE Bio Corp. | 13.68 Million USD | 100.005% |
| Accustem Sciences Inc. | -3.74 Million USD | 99.981% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 99.999% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | 99.85% |
| Q BioMed Inc. | -3.44 Million USD | 99.979% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 100.02% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 99.972% |
| Biomind Labs Inc. | -1 Million USD | 99.928% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 99.999% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 99.975% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 99.989% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 99.961% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | 97.587% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 99.995% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 99.963% |
| GB Sciences, Inc. | -1.42 Million USD | 99.949% |
| Alpha Cognition Inc. | -9.7 Million USD | 99.993% |
| HST Global, Inc. | -140.9 Thousand USD | 99.487% |
| CSL Limited | 3.7 Billion USD | 100.0% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 99.936% |
| Halberd Corporation | -75.05 Thousand USD | 99.037% |
| Enzolytics Inc. | -2.14 Million USD | 99.966% |
| Agentix Corp. | -1.37 Million USD | 99.947% |
| Resverlogix Corp. | -12.74 Million USD | 99.994% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 99.977% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 100.0% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 99.931% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 99.975% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 99.954% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 99.979% |
| AVAX Technologies, Inc. | 6.69 Million USD | 100.011% |
| Zenith Capital Corp. | -8.94 Million USD | 99.992% |
| Genscript Biotech Corporation | -415.79 Million USD | 100.0% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 95.851% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 99.971% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 99.579% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 99.964% |
| Kadimastem Ltd | -3.04 Million USD | 99.976% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 99.927% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 99.942% |
| BioStem Technologies, Inc. | -7.77 Million USD | 99.991% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 99.602% |
| LadRx Corporation | -3.82 Million USD | 99.981% |
| Cell Source, Inc. | -4.32 Million USD | 99.983% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 99.895% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 99.895% |
| NovAccess Global Inc. | -2.46 Million USD | 99.971% |
| Affymax, Inc. | -15.04 Million USD | 99.995% |
| Itoco Inc. | -919.14 Thousand USD | 99.921% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 99.983% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 99.935% |
| Mobile Lads Corp. | -554.55 Thousand USD | 99.87% |
| CytoDyn Inc. | -18.05 Million USD | 99.996% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | 97.128% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 99.672% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 99.872% |
| SYBLEU INC | -149.18 Thousand USD | 99.515% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 99.96% |
| International Stem Cell Corporation | -663 Thousand USD | 99.891% |
| Bioxytran, Inc. | -3.82 Million USD | 99.981% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 98.627% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | 96.446% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 99.998% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 99.955% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 99.902% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 99.977% |
| Neutra Corp. | -229.48 Thousand USD | 99.685% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 99.996% |
| PureTech Health plc | -146.19 Million USD | 100.0% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 99.997% |
| IXICO plc | -1.43 Million USD | 99.95% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 99.992% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.999% |
| CSL Limited | 3.81 Billion USD | 100.0% |
| Cellectis S.A. | -108.85 Million USD | 99.999% |